Tabula Rasa HealthCare to Participate in the 29th Annual Piper Jaffray Healthcare Conference


MOORESTOWN, N.J., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced that Chairman and CEO, Calvin Knowlton, Ph.D., President and Chief Marketing & New Business Development officer, Orsula Knowlton, PharmD, MBA, and Chief Financial Officer, Brian Adams, will participate in 29th Annual Piper Jaffray Healthcare Conference in New York City.

The TRHC Management Team’s presentation is scheduled on Wednesday, November 29, 2017 at 11:30 a.m. EST. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at The archived webcast and presentation materials will also be available for 90 days at the same URL.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk.  Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payors, providers and other healthcare organizations. For more information,


Bob East or Asher Dewhurst
Westwicke Partners

Dianne Semingson  
T: 215-870-0829